Impact of Universal Antiretroviral Treatment Eligibility on Rapid Treatment Initiation Among Young Adolescents with Human Immunodeficiency Virus in Sub-Saharan Africa
- PMID: 31682261
- PMCID: PMC7530553
- DOI: 10.1093/infdis/jiz547
Impact of Universal Antiretroviral Treatment Eligibility on Rapid Treatment Initiation Among Young Adolescents with Human Immunodeficiency Virus in Sub-Saharan Africa
Abstract
Background: Young adolescents with perinatally acquired human immunodeficiency virus (HIV) are at risk for poor care outcomes. We examined whether universal antiretroviral treatment (ART) eligibility policies (Treat All) improved rapid ART initiation after care enrollment among 10-14-year-olds in 7 sub-Saharan African countries.
Methods: Regression discontinuity analysis and data for 6912 patients aged 10-14-years were used to estimate changes in rapid ART initiation (within 30 days of care enrollment) after adoption of Treat All policies in 2 groups of countries: Uganda and Zambia (policy adopted in 2013) and Burundi, Democratic Republic of the Congo, Kenya, Malawi, and Rwanda (policy adopted in 2016).
Results: There were immediate increases in rapid ART initiation among young adolescents after national adoption of Treat All. Increases were greater in countries adopting the policy in 2016 than in those adopting it in 2013: 23.4 percentage points (pp) (95% confidence interval, 13.9-32.8) versus 11.2pp (2.5-19.9). However, the rate of increase in rapid ART initiation among 10-14-year-olds rose appreciably in countries with earlier treatment expansions, from 1.5pp per year before Treat All to 7.7pp per year afterward.
Conclusions: Universal ART eligibility has increased rapid treatment initiation among young adolescents enrolling in HIV care. Further research should assess their retention in care and viral suppression under Treat All.
Keywords: ART eligibility; ART initiation; Treat All; adolescents; regression discontinuity; sub-Saharan Africa.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Figures


Comment in
-
The Meaning of "Rapid" Antiretroviral Therapy Initiation for Adolescents With Human Immunodeficiency Virus in Sub-Saharan Africa.J Infect Dis. 2020 Aug 4;222(5):705-707. doi: 10.1093/infdis/jiz548. J Infect Dis. 2020. PMID: 31682259 Free PMC article. No abstract available.
Similar articles
-
Changes in rapid HIV treatment initiation after national "treat all" policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis.PLoS Med. 2019 Jun 10;16(6):e1002822. doi: 10.1371/journal.pmed.1002822. eCollection 2019 Jun. PLoS Med. 2019. PMID: 31181056 Free PMC article.
-
HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries.PLoS Med. 2018 Mar 23;15(3):e1002534. doi: 10.1371/journal.pmed.1002534. eCollection 2018 Mar. PLoS Med. 2018. PMID: 29570723 Free PMC article.
-
From policy to practice: exploring the implementation of antiretroviral therapy access and retention policies between 2013 and 2016 in six sub-Saharan African countries.BMC Health Serv Res. 2017 Nov 21;17(1):758. doi: 10.1186/s12913-017-2678-1. BMC Health Serv Res. 2017. PMID: 29162065 Free PMC article.
-
Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review.J Int AIDS Soc. 2015 Sep 16;18(1):20049. doi: 10.7448/IAS.18.1.20049. eCollection 2015. J Int AIDS Soc. 2015. PMID: 26385853 Free PMC article. Review.
-
Review of antiretroviral therapy coverage in 10 highest burden HIV countries in Africa: 2015-2020.J Med Virol. 2023 Jan;95(1):e28320. doi: 10.1002/jmv.28320. J Med Virol. 2023. PMID: 36397202 Review.
Cited by
-
Characterizing the HIV care continuum among children and adolescents with HIV in eastern and southern Africa in the era of "Universal Test and Treat": A systematic review and meta-analysis.J Int AIDS Soc. 2025 Jun;28(6):e26526. doi: 10.1002/jia2.26526. J Int AIDS Soc. 2025. PMID: 40515449 Free PMC article. Review.
-
The IeDEA harmonist data toolkit: A data quality and data sharing solution for a global HIV research consortium.J Biomed Inform. 2022 Jul;131:104110. doi: 10.1016/j.jbi.2022.104110. Epub 2022 Jun 6. J Biomed Inform. 2022. PMID: 35680074 Free PMC article.
-
Long-term HIV care outcomes under universal HIV treatment guidelines: A retrospective cohort study in 25 countries.PLoS Med. 2024 Mar 18;21(3):e1004367. doi: 10.1371/journal.pmed.1004367. eCollection 2024 Mar. PLoS Med. 2024. PMID: 38498589 Free PMC article.
-
Timeliness of antiretroviral therapy initiation in the era before universal treatment.Sci Rep. 2021 May 18;11(1):10508. doi: 10.1038/s41598-021-90043-7. Sci Rep. 2021. PMID: 34006927 Free PMC article.
-
Toward Universal HIV Treatment in Haiti: Time Trends in ART Retention After Expanded ART Eligibility in a National Cohort From 2011 to 2017.J Acquir Immune Defic Syndr. 2020 Jun 1;84(2):153-161. doi: 10.1097/QAI.0000000000002329. J Acquir Immune Defic Syndr. 2020. PMID: 32084052 Free PMC article.
References
-
- United Nations Children’s Fund (UNICEF). Children, HIV and AIDS: The world in 2030. New York, NY: UNICEF 2018.
-
- Idele P, Gillespie A, Porth T, et al. Epidemiology of HIV and AIDS among adolescents: current status, inequities, and data gaps. J Acquir Immune Defic Syndr 2014; 66(suppl 2):S144–53. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous